92 related articles for article (PubMed ID: 16380479)
1. Glibenclamide treatment recruits beta-cell subpopulation into elevated and sustained basal insulin synthetic activity.
Ling Z; Wang Q; Stangé G; In't Veld P; Pipeleers D
Diabetes; 2006 Jan; 55(1):78-85. PubMed ID: 16380479
[TBL] [Abstract][Full Text] [Related]
2. Interaction of glibenclamide and metformin at the level of translation in pancreatic β cells.
Wang Q; Cai Y; Van de Casteele M; Pipeleers D; Ling Z
J Endocrinol; 2011 Feb; 208(2):161-9. PubMed ID: 21084384
[TBL] [Abstract][Full Text] [Related]
3. Insulin exocytosis in Goto-Kakizaki rat beta-cells subjected to long-term glinide or sulfonylurea treatment.
Kawai J; Ohara-Imaizumi M; Nakamichi Y; Okamura T; Akimoto Y; Matsushima S; Aoyagi K; Kawakami H; Watanabe T; Watada H; Kawamori R; Nagamatsu S
Biochem J; 2008 May; 412(1):93-101. PubMed ID: 18254725
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic beta-cell line, MIN6.
Sawada F; Inoguchi T; Tsubouchi H; Sasaki S; Fujii M; Maeda Y; Morinaga H; Nomura M; Kobayashi K; Takayanagi R
Metabolism; 2008 Aug; 57(8):1038-45. PubMed ID: 18640379
[TBL] [Abstract][Full Text] [Related]
5. Glibenclamide activates translation in rat pancreatic beta cells through calcium-dependent mTOR, PKA and MEK signalling pathways.
Wang Q; Heimberg H; Pipeleers D; Ling Z
Diabetologia; 2008 Jul; 51(7):1202-12. PubMed ID: 18493739
[TBL] [Abstract][Full Text] [Related]
6. Sustained enhancement of Ca(2+) influx by glibenclamide induces apoptosis in RINm5F cells.
Iwakura T; Fujimoto S; Kagimoto S; Inada A; Kubota A; Someya Y; Ihara Y; Yamada Y; Seino Y
Biochem Biophys Res Commun; 2000 May; 271(2):422-8. PubMed ID: 10799313
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic rosiglitazone, metformin and glyburide treatment on beta-cell mass, function and insulin sensitivity in mZDF rats.
Atkinson LL; McDonald-Dyck C; Benkoczi C; Finegood DT
Diabetes Obes Metab; 2008 Sep; 10(9):780-90. PubMed ID: 17970758
[TBL] [Abstract][Full Text] [Related]
8. Sulfonylurea and glinide reduce insulin content, functional expression of K(ATP) channels, and accelerate apoptotic beta-cell death in the chronic phase.
Takahashi A; Nagashima K; Hamasaki A; Kuwamura N; Kawasaki Y; Ikeda H; Yamada Y; Inagaki N; Seino Y
Diabetes Res Clin Pract; 2007 Sep; 77(3):343-50. PubMed ID: 17316868
[TBL] [Abstract][Full Text] [Related]
9. Fluoride exposure impairs glucose tolerance via decreased insulin expression and oxidative stress.
García-Montalvo EA; Reyes-Pérez H; Del Razo LM
Toxicology; 2009 Sep; 263(2-3):75-83. PubMed ID: 19540901
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone acutely activates AMP-activated protein kinase and inhibits insulin secretion from beta cells.
Wang X; Zhou L; Shao L; Qian L; Fu X; Li G; Luo T; Gu Y; Li F; Li J; Zheng S; Luo M
Life Sci; 2007 Jun; 81(2):160-5. PubMed ID: 17544010
[TBL] [Abstract][Full Text] [Related]
11. Effects of 18alpha-glycyrrhizin on the pharmacodynamics and pharmacokinetics of glibenclamide in alloxan-induced diabetic rats.
Ao Y; Chen J; Yue J; Peng RX
Eur J Pharmacol; 2008 Jun; 587(1-3):330-5. PubMed ID: 18462715
[TBL] [Abstract][Full Text] [Related]
12. Prolonged L-alanine exposure induces changes in metabolism, Ca(2+) handling and desensitization of insulin secretion in clonal pancreatic beta-cells.
McClenaghan NH; Scullion SM; Mion B; Hewage C; Malthouse JP; Flatt PR; Newsholme P; Brennan L
Clin Sci (Lond); 2009 Feb; 116(4):341-51. PubMed ID: 18702613
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the effects of sulfonylurea exposure on pancreatic beta cell metabolism.
Brennan L; Hewage C; Malthouse JP; McClenaghan NH; Flatt PR; Newsholme P
FEBS J; 2006 Nov; 273(22):5160-8. PubMed ID: 17054712
[TBL] [Abstract][Full Text] [Related]
14. OATP1B3 is expressed in pancreatic β-islet cells and enhances the insulinotropic effect of the sulfonylurea derivative glibenclamide.
Meyer Zu Schwabedissen HE; Boettcher K; Steiner T; Schwarz UI; Keiser M; Kroemer HK; Siegmund W
Diabetes; 2014 Feb; 63(2):775-84. PubMed ID: 24150606
[TBL] [Abstract][Full Text] [Related]
15. Increased oxygen radical formation and mitochondrial dysfunction mediate beta cell apoptosis under conditions of AMP-activated protein kinase stimulation.
Cai Y; Martens GA; Hinke SA; Heimberg H; Pipeleers D; Van de Casteele M
Free Radic Biol Med; 2007 Jan; 42(1):64-78. PubMed ID: 17157194
[TBL] [Abstract][Full Text] [Related]
16. Glucose, regulator of survival and phenotype of pancreatic beta cells.
Martens GA; Pipeleers D
Vitam Horm; 2009; 80():507-39. PubMed ID: 19251048
[TBL] [Abstract][Full Text] [Related]
17. Metabolic and ionic coupling factors in amino acid-stimulated insulin release in pancreatic beta-HC9 cells.
Doliba NM; Wehrli SL; Vatamaniuk MZ; Qin W; Buettger CW; Collins HW; Matschinsky FM
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1507-19. PubMed ID: 17264232
[TBL] [Abstract][Full Text] [Related]
18. Exendin 4 controls insulin production in rat islet beta cells predominantly by potentiation of glucose-stimulated proinsulin biosynthesis at the translational level.
Alarcon C; Wicksteed B; Rhodes CJ
Diabetologia; 2006 Dec; 49(12):2920-9. PubMed ID: 17053883
[TBL] [Abstract][Full Text] [Related]
19. (R)-ACX, a pancreatic beta-cell selective sulfonylurea, does not aggravate myocardial ischemia-reperfusion damage.
Namekata I; Yamaguchi Y; Moriguchi S; Yamazaki S; Terasawa A; Yamagishi R; Aikawa T; Saito T; Kurashima K; Seri K; Imamura Y; Akita H; Shigenobu K; Tanaka H
Eur J Pharmacol; 2007 Dec; 577(1-3):211-8. PubMed ID: 17927975
[TBL] [Abstract][Full Text] [Related]
20. Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets.
Del Guerra S; Marselli L; Lupi R; Boggi U; Mosca F; Benzi L; Del Prato S; Marchetti P
J Diabetes Complications; 2005; 19(1):60-4. PubMed ID: 15642492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
